Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 2,697 | 51,236 | 4 | 34 | 351 |
| Gross Profit | 2,697 | 51,236 | 4 | 34 | 351 |
| Operating Expenses | 33,511 | 38,847 | 31,010 | 43,307 | 37,499 |
| Operating Income | -30,814 | 12,389 | -31,006 | -43,273 | -37,148 |
| Other Income | -95 | 5 | -69 | -39 | -67 |
| Pre-tax Income | -30,909 | 12,394 | -31,075 | -43,312 | -37,215 |
| Income Tax | N/A | 3,297 | -463 | -741 | N/A |
| Net Income Continuous | -31,684 | 7,545 | -30,696 | -42,571 | -37,215 |
| Net Income | $-31,684 | $7,545 | $-30,696 | $-42,571 | $-37,215 |
| EPS Basic Total Ops | -0.54 | 0.28 | -0.69 | -0.97 | -0.88 |
| EPS Basic Continuous Ops | -0.54 | 0.28 | -0.69 | -0.97 | -0.88 |
| EPS Diluted Total Ops | -0.54 | 0.28 | -0.69 | -0.97 | -0.88 |
| EPS Diluted Continuous Ops | -0.54 | 0.28 | -0.69 | -0.97 | -0.88 |
| EPS Diluted Before Non-Recurring Items | -0.54 | 0.14 | -0.68 | N/A | N/A |
| EBITDA(a) | $-29,113 | $13,781 | $-29,823 | $-42,109 | $-35,924 |